FindTrial
Sign In

Role of Fibro scan and non-invasive markers for Fibrosis in patients with non-alcoholic fatty liver

Association of fibro-scan and other non-invasive markers of fibrosis in non-alcoholic fatty liver disease with insulin resistance. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/01/061814
Enrollment
100
Registered
2024-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

Intervention1: NA: NA Control Intervention1: NA: NA

Sponsors

Kasturba Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age of 18 years and more, irrespective of gender. Non-alcoholic patients incidentally diagnosed to have fatty liver on ultrasound of abdomen (hyperechoic liver with echotexture of the liver was brighter than the kidney,blurred vascular margins and deep attenuation of ultrasound signal)

Exclusion criteria

Exclusion criteria: History of alcohol intake more than 20 g per day daily for the last 2 years Hepatitis B and hepatitis C positive individuals Biliary obstruction on ultrasonography. Past history of diagnosis of liver cirrhosis Malabsorption Pregnancy Cardio-respiratory, renal comorbidities

Design outcomes

Primary

MeasureTime frame
To determine the role of fibro-scan and other non-invasive predictors of fibrosis in NAFLD (Non-Alcoholic Fatty Liver Disease).Timepoint: 1 year—

Secondary

MeasureTime frame
To correlate fibro scan and other non-invasive markers of fibrosis with insulin resistance in the form of HOMA-IR levels.Timepoint: 1 year—

Countries

India

Contacts

Public ContactDr Anand Kumar R

Manipal Academy of Higher Education

bhat.ganesh@manipal.edu9900791615

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026